Ian Mortimer, CFO & COO at Xenon Pharmaceuticals Inc. (XENE), bought 15,000 shares at $2.85 ($43K) on 2017-08-10, disclosed to the SEC on 2017-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.85 | 5,000 | $14K | 32.9% |
| 2 | $2.90 | 10,000 | $29K | 67.1% |
| Total | $2.88 avg | 15,000 | $43K | 100% |
| Filing → |
| XENE | SELL | 2026-03-11 | $17.6M | — | Filing → |
| XENE | SELL | 2026-01-02 | $1.8M | — | Filing → |
| XENE | SELL | 2025-12-09 | $2.3M | — | Filing → |